Literature DB >> 34389172

Integration of personalized drug delivery systems into digital health.

Dhara Raijada1, Katarzyna Wac2, Emanuel Greisen3, Jukka Rantanen1, Natalja Genina4.   

Abstract

Personalized drug delivery systems (PDDS), implying the patient-tailored dose, dosage form, frequency of administration and drug release kinetics, and digital health platforms for diagnosis and treatment monitoring, patient adherence, and traceability of drug products, are emerging scientific areas. Both fields are advancing at a fast pace. However, despite the strong complementary nature of these disciplines, there are only a few successful examples of merging these areas. Therefore, it is important and timely to combine PDDS with an increasing number of high-end digital health solutions to create an interactive feedback loop between the actual needs of each patient and the drug products. This review provides an overview of advanced design solutions for new products such as interactive personalized treatment that would interconnect the pharmaceutical and digital worlds. Furthermore, we discuss the recent advancements in the pharmaceutical supply chain (PSC) management and related limitations of the current mass production model. We summarize the current state of the art and envision future directions and potential development areas.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2D barcodes; Anti-counterfeiting; Digital therapeutics; Internet of Things (IoT); Personalized medicine; Pharmaceutical supply chain; Smartphone; Traceability; Track and trace; Unique identifiers

Mesh:

Substances:

Year:  2021        PMID: 34389172     DOI: 10.1016/j.addr.2021.113857

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  7 in total

Review 1.  Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care.

Authors:  Hayam Y Giravi; Zack Biskupiak; Linda S Tyler; Grzegorz Bulaj
Journal:  Front Digit Health       Date:  2022-06-13

2.  Scenarios for 3D printing of personalized medicines - A case study.

Authors:  Netta Beer; Ingrid Hegger; Susanne Kaae; Marie Louise De Bruin; Natalja Genina; Teresa Leonardo Alves; Joelle Hoebert; Sofia Kälvemark Sporrong
Journal:  Explor Res Clin Soc Pharm       Date:  2021-09-25

3.  Data-enriched edible pharmaceuticals (DEEPs): Patients' preferences, perceptions, and acceptability of new dosage forms and their digital aspects - An interview study.

Authors:  Meie Chao; Natalja Genina; Netta Beer; Sofia Kälvemark Sporrong
Journal:  Explor Res Clin Soc Pharm       Date:  2022-04-22

Review 4.  The Evolution of the 3D-Printed Drug Delivery Systems: A Review.

Authors:  Ildikó Bácskay; Zoltán Ujhelyi; Pálma Fehér; Petra Arany
Journal:  Pharmaceutics       Date:  2022-06-21       Impact factor: 6.525

5.  Machine Learning and Machine Vision Accelerate 3D Printed Orodispersible Film Development.

Authors:  Colm S O'Reilly; Moe Elbadawi; Neel Desai; Simon Gaisford; Abdul W Basit; Mine Orlu
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

6.  Potential next-generation medications for self-administered platforms.

Authors:  Cheng-Han Chen; Chao-Min Cheng
Journal:  J Control Release       Date:  2021-12-24       Impact factor: 9.776

Review 7.  The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?

Authors:  Ioannis I Andreadis; Christos I Gioumouxouzis; Georgios K Eleftheriadis; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.